Cargando…
Applicability of the EFSA Opinion on site‐directed nucleases type 3 for the safety assessment of plants developed using site‐directed nucleases type 1 and 2 and oligonucleotide‐directed mutagenesis
The European Commission requested the EFSA Panel on Genetically Modified Organisms (GMO) to assess whether section 4 (hazard identification) and the conclusions of EFSA's Scientific opinion on the risk assessment of plants developed using zinc finger nuclease type 3 technique (ZFN‐3) and other...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684970/ https://www.ncbi.nlm.nih.gov/pubmed/33281977 http://dx.doi.org/10.2903/j.efsa.2020.6299 |
_version_ | 1783613105231626240 |
---|---|
author | Naegeli, Hanspeter Bresson, Jean‐Louis Dalmay, Tamas Dewhurst, Ian Crawford Epstein, Michelle M Firbank, Leslie George Guerche, Philippe Hejatko, Jan Moreno, Francisco Javier Mullins, Ewen Nogué, Fabien Sánchez Serrano, Jose Juan Savoini, Giovanni Veromann, Eve Veronesi, Fabio Casacuberta, Josep Gennaro, Andrea Paraskevopoulos, Konstantinos Raffaello, Tommaso Rostoks, Nils |
author_facet | Naegeli, Hanspeter Bresson, Jean‐Louis Dalmay, Tamas Dewhurst, Ian Crawford Epstein, Michelle M Firbank, Leslie George Guerche, Philippe Hejatko, Jan Moreno, Francisco Javier Mullins, Ewen Nogué, Fabien Sánchez Serrano, Jose Juan Savoini, Giovanni Veromann, Eve Veronesi, Fabio Casacuberta, Josep Gennaro, Andrea Paraskevopoulos, Konstantinos Raffaello, Tommaso Rostoks, Nils |
collection | PubMed |
description | The European Commission requested the EFSA Panel on Genetically Modified Organisms (GMO) to assess whether section 4 (hazard identification) and the conclusions of EFSA's Scientific opinion on the risk assessment of plants developed using zinc finger nuclease type 3 technique (ZFN‐3) and other site‐directed nucleases (SDN) with similar function are valid for plants developed via SDN‐1, SDN‐2 and oligonucleotide‐directed mutagenesis (ODM). In delivering this Opinion, the GMO Panel compared the hazards associated with plants produced via SDN‐1, SDN‐2 and ODM with those associated with plants obtained via both SDN‐3 and conventional breeding. Unlike for SDN‐3 methods, the application of SDN‐1, SDN‐2 and ODM approaches aims to modify genomic sequences in a way which can result in plants not containing any transgene, intragene or cisgene. Consequently, the GMO Panel concludes that those considerations which are specifically related to the presence of a transgene, intragene or cisgene included in section 4 and the conclusions of the Opinion on SDN‐3 are not relevant to plants obtained via SDN‐1, SDN‐2 or ODM as defined in this Opinion. Overall, the GMO Panel did not identify new hazards specifically linked to the genomic modification produced via SDN‐1, SDN‐2 or ODM as compared with both SDN‐3 and conventional breeding. Furthermore, the GMO Panel considers that the existing Guidance for risk assessment of food and feed from genetically modified plants and the Guidance on the environmental risk assessment of genetically modified plants are sufficient but are only partially applicable to plants generated via SDN‐1, SDN‐2 or ODM. Indeed, those guidance documents’ requirements that are linked to the presence of exogenous DNA are not relevant for the risk assessment of plants developed via SDN‐1, SDN‐2 or ODM approaches if the genome of the final product does not contain exogenous DNA. |
format | Online Article Text |
id | pubmed-7684970 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76849702020-12-03 Applicability of the EFSA Opinion on site‐directed nucleases type 3 for the safety assessment of plants developed using site‐directed nucleases type 1 and 2 and oligonucleotide‐directed mutagenesis Naegeli, Hanspeter Bresson, Jean‐Louis Dalmay, Tamas Dewhurst, Ian Crawford Epstein, Michelle M Firbank, Leslie George Guerche, Philippe Hejatko, Jan Moreno, Francisco Javier Mullins, Ewen Nogué, Fabien Sánchez Serrano, Jose Juan Savoini, Giovanni Veromann, Eve Veronesi, Fabio Casacuberta, Josep Gennaro, Andrea Paraskevopoulos, Konstantinos Raffaello, Tommaso Rostoks, Nils EFSA J Scientific Opinion The European Commission requested the EFSA Panel on Genetically Modified Organisms (GMO) to assess whether section 4 (hazard identification) and the conclusions of EFSA's Scientific opinion on the risk assessment of plants developed using zinc finger nuclease type 3 technique (ZFN‐3) and other site‐directed nucleases (SDN) with similar function are valid for plants developed via SDN‐1, SDN‐2 and oligonucleotide‐directed mutagenesis (ODM). In delivering this Opinion, the GMO Panel compared the hazards associated with plants produced via SDN‐1, SDN‐2 and ODM with those associated with plants obtained via both SDN‐3 and conventional breeding. Unlike for SDN‐3 methods, the application of SDN‐1, SDN‐2 and ODM approaches aims to modify genomic sequences in a way which can result in plants not containing any transgene, intragene or cisgene. Consequently, the GMO Panel concludes that those considerations which are specifically related to the presence of a transgene, intragene or cisgene included in section 4 and the conclusions of the Opinion on SDN‐3 are not relevant to plants obtained via SDN‐1, SDN‐2 or ODM as defined in this Opinion. Overall, the GMO Panel did not identify new hazards specifically linked to the genomic modification produced via SDN‐1, SDN‐2 or ODM as compared with both SDN‐3 and conventional breeding. Furthermore, the GMO Panel considers that the existing Guidance for risk assessment of food and feed from genetically modified plants and the Guidance on the environmental risk assessment of genetically modified plants are sufficient but are only partially applicable to plants generated via SDN‐1, SDN‐2 or ODM. Indeed, those guidance documents’ requirements that are linked to the presence of exogenous DNA are not relevant for the risk assessment of plants developed via SDN‐1, SDN‐2 or ODM approaches if the genome of the final product does not contain exogenous DNA. John Wiley and Sons Inc. 2020-11-24 /pmc/articles/PMC7684970/ /pubmed/33281977 http://dx.doi.org/10.2903/j.efsa.2020.6299 Text en © 2020 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made. |
spellingShingle | Scientific Opinion Naegeli, Hanspeter Bresson, Jean‐Louis Dalmay, Tamas Dewhurst, Ian Crawford Epstein, Michelle M Firbank, Leslie George Guerche, Philippe Hejatko, Jan Moreno, Francisco Javier Mullins, Ewen Nogué, Fabien Sánchez Serrano, Jose Juan Savoini, Giovanni Veromann, Eve Veronesi, Fabio Casacuberta, Josep Gennaro, Andrea Paraskevopoulos, Konstantinos Raffaello, Tommaso Rostoks, Nils Applicability of the EFSA Opinion on site‐directed nucleases type 3 for the safety assessment of plants developed using site‐directed nucleases type 1 and 2 and oligonucleotide‐directed mutagenesis |
title | Applicability of the EFSA Opinion on site‐directed nucleases type 3 for the safety assessment of plants developed using site‐directed nucleases type 1 and 2 and oligonucleotide‐directed mutagenesis |
title_full | Applicability of the EFSA Opinion on site‐directed nucleases type 3 for the safety assessment of plants developed using site‐directed nucleases type 1 and 2 and oligonucleotide‐directed mutagenesis |
title_fullStr | Applicability of the EFSA Opinion on site‐directed nucleases type 3 for the safety assessment of plants developed using site‐directed nucleases type 1 and 2 and oligonucleotide‐directed mutagenesis |
title_full_unstemmed | Applicability of the EFSA Opinion on site‐directed nucleases type 3 for the safety assessment of plants developed using site‐directed nucleases type 1 and 2 and oligonucleotide‐directed mutagenesis |
title_short | Applicability of the EFSA Opinion on site‐directed nucleases type 3 for the safety assessment of plants developed using site‐directed nucleases type 1 and 2 and oligonucleotide‐directed mutagenesis |
title_sort | applicability of the efsa opinion on site‐directed nucleases type 3 for the safety assessment of plants developed using site‐directed nucleases type 1 and 2 and oligonucleotide‐directed mutagenesis |
topic | Scientific Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684970/ https://www.ncbi.nlm.nih.gov/pubmed/33281977 http://dx.doi.org/10.2903/j.efsa.2020.6299 |
work_keys_str_mv | AT applicabilityoftheefsaopiniononsitedirectednucleasestype3forthesafetyassessmentofplantsdevelopedusingsitedirectednucleasestype1and2andoligonucleotidedirectedmutagenesis AT naegelihanspeter applicabilityoftheefsaopiniononsitedirectednucleasestype3forthesafetyassessmentofplantsdevelopedusingsitedirectednucleasestype1and2andoligonucleotidedirectedmutagenesis AT bressonjeanlouis applicabilityoftheefsaopiniononsitedirectednucleasestype3forthesafetyassessmentofplantsdevelopedusingsitedirectednucleasestype1and2andoligonucleotidedirectedmutagenesis AT dalmaytamas applicabilityoftheefsaopiniononsitedirectednucleasestype3forthesafetyassessmentofplantsdevelopedusingsitedirectednucleasestype1and2andoligonucleotidedirectedmutagenesis AT dewhurstiancrawford applicabilityoftheefsaopiniononsitedirectednucleasestype3forthesafetyassessmentofplantsdevelopedusingsitedirectednucleasestype1and2andoligonucleotidedirectedmutagenesis AT epsteinmichellem applicabilityoftheefsaopiniononsitedirectednucleasestype3forthesafetyassessmentofplantsdevelopedusingsitedirectednucleasestype1and2andoligonucleotidedirectedmutagenesis AT firbanklesliegeorge applicabilityoftheefsaopiniononsitedirectednucleasestype3forthesafetyassessmentofplantsdevelopedusingsitedirectednucleasestype1and2andoligonucleotidedirectedmutagenesis AT guerchephilippe applicabilityoftheefsaopiniononsitedirectednucleasestype3forthesafetyassessmentofplantsdevelopedusingsitedirectednucleasestype1and2andoligonucleotidedirectedmutagenesis AT hejatkojan applicabilityoftheefsaopiniononsitedirectednucleasestype3forthesafetyassessmentofplantsdevelopedusingsitedirectednucleasestype1and2andoligonucleotidedirectedmutagenesis AT morenofranciscojavier applicabilityoftheefsaopiniononsitedirectednucleasestype3forthesafetyassessmentofplantsdevelopedusingsitedirectednucleasestype1and2andoligonucleotidedirectedmutagenesis AT mullinsewen applicabilityoftheefsaopiniononsitedirectednucleasestype3forthesafetyassessmentofplantsdevelopedusingsitedirectednucleasestype1and2andoligonucleotidedirectedmutagenesis AT noguefabien applicabilityoftheefsaopiniononsitedirectednucleasestype3forthesafetyassessmentofplantsdevelopedusingsitedirectednucleasestype1and2andoligonucleotidedirectedmutagenesis AT sanchezserranojosejuan applicabilityoftheefsaopiniononsitedirectednucleasestype3forthesafetyassessmentofplantsdevelopedusingsitedirectednucleasestype1and2andoligonucleotidedirectedmutagenesis AT savoinigiovanni applicabilityoftheefsaopiniononsitedirectednucleasestype3forthesafetyassessmentofplantsdevelopedusingsitedirectednucleasestype1and2andoligonucleotidedirectedmutagenesis AT veromanneve applicabilityoftheefsaopiniononsitedirectednucleasestype3forthesafetyassessmentofplantsdevelopedusingsitedirectednucleasestype1and2andoligonucleotidedirectedmutagenesis AT veronesifabio applicabilityoftheefsaopiniononsitedirectednucleasestype3forthesafetyassessmentofplantsdevelopedusingsitedirectednucleasestype1and2andoligonucleotidedirectedmutagenesis AT casacubertajosep applicabilityoftheefsaopiniononsitedirectednucleasestype3forthesafetyassessmentofplantsdevelopedusingsitedirectednucleasestype1and2andoligonucleotidedirectedmutagenesis AT gennaroandrea applicabilityoftheefsaopiniononsitedirectednucleasestype3forthesafetyassessmentofplantsdevelopedusingsitedirectednucleasestype1and2andoligonucleotidedirectedmutagenesis AT paraskevopouloskonstantinos applicabilityoftheefsaopiniononsitedirectednucleasestype3forthesafetyassessmentofplantsdevelopedusingsitedirectednucleasestype1and2andoligonucleotidedirectedmutagenesis AT raffaellotommaso applicabilityoftheefsaopiniononsitedirectednucleasestype3forthesafetyassessmentofplantsdevelopedusingsitedirectednucleasestype1and2andoligonucleotidedirectedmutagenesis AT rostoksnils applicabilityoftheefsaopiniononsitedirectednucleasestype3forthesafetyassessmentofplantsdevelopedusingsitedirectednucleasestype1and2andoligonucleotidedirectedmutagenesis |